{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:26:47Z","timestamp":1760239607741,"version":"build-2065373602"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.gtc.2023.05.009","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T15:53:42Z","timestamp":1687276422000},"page":"609-627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Health Care Maintenance in Pediatric Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"52","author":[{"given":"Elana B.","family":"Mitchel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2023.05.009_bib1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib2","first-page":"619","article-title":"Prevalence of Inflammatory Bowel Disease in Pediatric and Adult Populations: Recent Estimates From Large National Databases in the United States, 2007-2016","volume":"26","author":"Ye","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib3","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ajg.2017.97","article-title":"Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases","volume":"112","author":"Benchimol","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2023.05.009_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MPG.0b013e31828f21b4","article-title":"Increasing incidence of paediatric inflammatory bowel disease in northern Stockholm County, 2002-2007","volume":"57","author":"Malmborg","year":"2013","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/ibd.21152","article-title":"Natural history of Crohn's disease: comparison between childhood- and adult-onset disease","volume":"16","author":"Pigneur","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","article-title":"Inflammatory Bowel Disease in Children and Adolescents","volume":"169","author":"Rosen","year":"2015","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.gtc.2023.05.009_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/gutjnl-2018-317987","article-title":"Designing clinical trials in paediatric inflammatory bowel diseases: a PIBDnet commentary","volume":"69","author":"Turner","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2023.05.009_bib8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1053\/j.gastro.2008.06.081","article-title":"Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease","volume":"135","author":"Van Limbergen","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2023.05.009_bib9","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1971","article-title":"Health Care Maintenance for the Pediatric Patient With Inflammatory Bowel Disease","volume":"138","author":"DeFilippis","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.gtc.2023.05.009_bib10","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/ibd\/izab155","article-title":"Health Maintenance Consensus for Adults With Inflammatory Bowel Disease","volume":"27","author":"Syal","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib11","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1097\/MIB.0b013e318281f5b5","article-title":"Health maintenance and vaccination strategies in pediatric inflammatory bowel disease","volume":"19","author":"Breglio","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpeds.2020.04.002","article-title":"Gaps Exist in the Comprehensive Care of Children with Inflammatory Bowel Diseases","volume":"224","author":"Michel","year":"2020","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.gtc.2023.05.009_bib13","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/MPG.0000000000002703","article-title":"Patterns of Primary, Specialty, Urgent Care, and Emergency Department Care in Children With Inflammatory Bowel Diseases","volume":"71","author":"Michel","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10620-010-1329-8","article-title":"Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients?","volume":"56","author":"Selby","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2023.05.009_bib15","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1002\/ibd.21667","article-title":"Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge","volume":"17","author":"Wasan","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11894-018-0621-1","article-title":"Health Maintenance in Inflammatory Bowel Disease","volume":"20","author":"Mir","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.gtc.2023.05.009_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ibd.20266","article-title":"Receipt of preventive health services by IBD patients is significantly lower than by primary care patients","volume":"14","author":"Selby","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease","volume":"112","author":"Farraye","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2023.05.009_bib19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/ibd\/izy336","article-title":"Anthropometric Measures in Adolescents With Inflammatory Bowel Disease: A Population-Based Study","volume":"25","author":"Ghersin","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2015\/950286","article-title":"Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review","volume":"29","author":"Alibrahim","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/jgh.14950","article-title":"Is fecal calprotectin an accurate marker in the management of Crohn's disease?","volume":"35","author":"Vernia","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.MPG.0000163736.30261.82","article-title":"Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria","volume":"41","year":"2005","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.MIB.0000437735.11953.68","article-title":"Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: evaluation of the porto IBD group \"growth relapse and outcomes with therapy\" (GROWTH CD) study","volume":"20","author":"Levine","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib24","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cgh.2013.09.006","article-title":"Treat to target: a proposed new paradigm for the management of Crohn's disease","volume":"13","author":"Bouguen","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/apt.13475","article-title":"Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease","volume":"43","author":"Shah","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2023.05.009_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/j.gastro.2013.10.027","article-title":"Increased effectiveness of early therapy with anti-tumor necrosis factor-alpha vs an immunomodulator in children with Crohn's disease","volume":"146","author":"Walters","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2023.05.009_bib27","first-page":"603","article-title":"Immunization status in children with inflammatory bowel disease","volume":"173","author":"Longuet","year":"2014","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.gtc.2023.05.009_bib28","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/ibd\/izz264","article-title":"Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN","volume":"26","author":"Martinelli","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.MIB.0000437737.68841.87","article-title":"Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement","volume":"20","author":"Wasan","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.gtc.2023.05.009_bib31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00054725-200409000-00028","article-title":"Guidelines for immunizations in patients with inflammatory bowel disease","volume":"10","author":"Sands","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/MPG.0b013e31824d1438","article-title":"Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto Group commentary","volume":"54","author":"Veereman-Wauters","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ajg.2012.406","article-title":"Increased risk of pneumonia among patients with inflammatory bowel disease","volume":"108","author":"Long","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2023.05.009_bib34","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.cgh.2017.12.052","article-title":"Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study","volume":"16","author":"Khan","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/apt.12182","article-title":"Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease","volume":"37","author":"Long","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2023.05.009_bib36","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/ibd\/izy131","article-title":"Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib","volume":"24","author":"Winthrop","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib37","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.cgh.2006.09.019","article-title":"Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease","volume":"4","author":"Gupta","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/CEG.S42514","article-title":"Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample","volume":"6","author":"Stobaugh","year":"2013","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.gtc.2023.05.009_bib39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ibd\/izy243","article-title":"Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease","volume":"25","author":"Tinsley","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib40","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cgh.2007.02.035","article-title":"Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease","volume":"5","author":"Mamula","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib41","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.vaccine.2022.02.027","article-title":"Immune response to influenza and pneumococcal vaccines in adults with inflammatory bowel disease: A systematic review and meta-analysis of 1429 patients","volume":"40","author":"Muller","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.gtc.2023.05.009_bib42","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MIB.0000000000000615","article-title":"Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial","volume":"22","author":"deBruyn","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/gutjnl-2020-324000","article-title":"SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting","volume":"70","author":"Siegel","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2023.05.009_bib44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S2468-1253(22)00005-X","article-title":"COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study","volume":"7","author":"Alexander","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib45","doi-asserted-by":"crossref","first-page":"462","DOI":"10.14309\/ajg.0000000000001619","article-title":"Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases","volume":"117","author":"Kappelman","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2023.05.009_bib46","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/ibd\/izac138","article-title":"Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease","volume":"29","author":"Weaver","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib47","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.cgh.2022.01.056","article-title":"Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases","volume":"20","author":"Long","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib48","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ibd.20378","article-title":"Guidelines for the management of growth failure in childhood inflammatory bowel disease","volume":"14","author":"Heuschkel","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib49","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1053\/j.gastro.2006.12.003","article-title":"Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children","volume":"132","author":"Hyams","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2023.05.009_bib50","first-page":"S73","article-title":"The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD","volume":"2","author":"Bernstein","year":"2019","journal-title":"J\u00a0Can Assoc Gastroenterol"},{"key":"10.1016\/j.gtc.2023.05.009_bib51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11914-021-00691-x","article-title":"Bone Health in Pediatric Patients with IBD: What Is New?","volume":"19","author":"Gordon","year":"2021","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.gtc.2023.05.009_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MPG.0b013e31821988a3","article-title":"Skeletal health of children and adolescents with inflammatory bowel disease","volume":"53","author":"Pappa","year":"2011","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib53","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.gastro.2020.07.065","article-title":"Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program","volume":"160","author":"Ricciuto","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2023.05.009_bib54","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/ecco-jcc\/jjaa197","article-title":"Diagnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn's Disease","volume":"15","author":"Ricciuto","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.gtc.2023.05.009_bib55","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.cgh.2008.07.010","article-title":"Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn's disease: results of the REACH study","volume":"6","author":"Thayu","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib56","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.3748\/wjg.15.2570","article-title":"Nutritional status and nutritional therapy in inflammatory bowel diseases","volume":"15","author":"Hartman","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2023.05.009_bib57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ibd\/izy271","article-title":"A\u00a0Systematic Review of Micronutrient Deficiencies in Pediatric Inflammatory Bowel Disease","volume":"25","author":"Fritz","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib58","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/ibd.22906","article-title":"Micronutrient deficiencies in inflammatory bowel disease: from A to zinc","volume":"18","author":"Hwang","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib59","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1542\/peds.2006-0841","article-title":"Vitamin D status in children and young adults with inflammatory bowel disease","volume":"118","author":"Pappa","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.gtc.2023.05.009_bib60","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2147\/JIR.S363840","article-title":"The Role of Vitamin D in Immune System and Inflammatory Bowel Disease","volume":"15","author":"Wu","year":"2022","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.gtc.2023.05.009_bib61","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/MPG.0b013e3181da4d8b","article-title":"Slow hematological recovery in children with IBD-associated anemia in cases of \"expectant management\"","volume":"51","author":"Pels","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib62","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1097\/MIB.0000000000000191","article-title":"Anemia in a population-based IBD cohort (ICURE): still high prevalence after 1 year, especially among pediatric patients","volume":"20","author":"Sjoberg","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib63","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MPG.0000000000002885","article-title":"Anemia in Children With Inflammatory Bowel Disease: A Position Paper by the IBD Committee of the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition","volume":"71","author":"Goyal","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib64","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/ibd\/izaa288","article-title":"Utilization of an Electronic Medical Record-integrated Dashboard Improves Identification and Treatment of Anemia and Iron Deficiency in Pediatric Inflammatory Bowel Disease","volume":"27","author":"Breton","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib65","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/MEG.0000000000000200","article-title":"Anaemia from a patient perspective in inflammatory bowel disease: results from the European Federation of Crohn's and Ulcerative Colitis Association's online survey","volume":"26","author":"Danese","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib66","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1524-4733.2005.00058.x","article-title":"Economic burden of patients with anemia in selected diseases","volume":"8","author":"Ershler","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.gtc.2023.05.009_bib67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.MIB.0000196646.64615.db","article-title":"Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients","volume":"12","author":"Wells","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib68","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ecco-jcc\/jjy029","article-title":"Ocular Manifestations of Paediatric Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"12","author":"Ottaviano","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.gtc.2023.05.009_bib69","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/ibd.20470","article-title":"Inflammatory bowel disease in children and adolescents in Italy: data from the pediatric national IBD register (1996-2003)","volume":"14","author":"Castro","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib70","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MPG.0b013e3181ca4db4","article-title":"Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity","volume":"51","author":"Dotson","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib71","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/00099228221078105","article-title":"Ocular Complications of Pediatric Inflammatory Bowel Disease: A Case Series From a Pediatric Tertiary Medical Center","volume":"61","author":"Rohani","year":"2022","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.gtc.2023.05.009_bib72","first-page":"170","article-title":"Asymptomatic transient uveitis in children with inflammatory bowel disease","volume":"133","author":"Daum","year":"1979","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.gtc.2023.05.009_bib73","first-page":"397","article-title":"Asymptomatic uveitis in children with chronic inflammatory bowel diseases","volume":"17","author":"Hofley","year":"1993","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib74","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/MIB.0000000000001079","article-title":"Ocular Involvement in Children with Inflammatory Bowel Disease","volume":"23","author":"Naviglio","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib75","first-page":"467","article-title":"Cutaneous malignancies in patients with inflammatory bowel disease","volume":"8","author":"Long","year":"2012","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib76","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"Long","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2023.05.009_bib77","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1097\/MIB.0000000000001191","article-title":"Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma","volume":"23","author":"Nissen","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib78","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cgh.2009.11.024","article-title":"Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease","volume":"8","author":"Long","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib79","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.3748\/wjg.v20.i29.9872","article-title":"Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis","volume":"20","author":"Kim","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2023.05.009_bib80","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2020.12.036","article-title":"Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis","volume":"160","author":"Wijnands","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2023.05.009_bib81","doi-asserted-by":"crossref","first-page":"j3951","DOI":"10.1136\/bmj.j3951","article-title":"Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014","volume":"358","author":"Olen","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.gtc.2023.05.009_bib82","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12887-021-02966-9","article-title":"Colorectal Cancer associated with pediatric inflammatory bowel disease: a case series","volume":"21","author":"Kim","year":"2021","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.gtc.2023.05.009_bib83","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.3748\/wjg.v25.i30.4148","article-title":"Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments","volume":"25","author":"Clarke","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gtc.2023.05.009_bib84","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MPG.0b013e3182841263","article-title":"Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition","volume":"56","author":"Mackner","year":"2013","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib85","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MOP.0000000000000129","article-title":"Pediatric inflammatory bowel disease and depression: treatment implications","volume":"26","author":"Keethy","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.gtc.2023.05.009_bib86","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/MPG.0000000000000696","article-title":"Health-related quality of life in youth with Crohn disease: role of disease activity and parenting stress","volume":"60","author":"Gray","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib87","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/ibd\/izaa115","article-title":"Systematic Review: Psychosocial Correlates of Pain in Pediatric Inflammatory Bowel Disease","volume":"27","author":"Murphy","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib88","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/MPG.0000000000002365","article-title":"Substance Use in Adolescents and Young Adults With Inflammatory Bowel Diseases: An Exploratory Cluster Analysis","volume":"69","author":"Plevinsky","year":"2019","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib89","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MPG.0000000000001474","article-title":"Prevalence and Patterns of Marijuana Use in Young Adults With Inflammatory Bowel Disease","volume":"64","author":"Phatak","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib90","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.amepre.2016.01.029","article-title":"Substance Use Patterns Through Early Adulthood: Results for Youth With and Without Chronic Conditions","volume":"51","author":"Wisk","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.gtc.2023.05.009_bib91","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPG.0000000000001393","article-title":"Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms a Mile High","volume":"64","author":"Hoffenberg","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2023.05.009_bib92","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/fampra\/cms035","article-title":"Family planning and inflammatory bowel disease: the patient and the practitioner","volume":"30","author":"Toomey","year":"2013","journal-title":"Fam Pract"},{"key":"10.1016\/j.gtc.2023.05.009_bib93","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MIB.0000000000000606","article-title":"Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases","volume":"22","author":"Gawron","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib94","first-page":"101","article-title":"Fertility and Contraception in Women With Inflammatory Bowel Disease","volume":"12","author":"Martin","year":"2016","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2023.05.009_bib95","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/AOG.0b013e3182994c43","article-title":"Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis","volume":"122","author":"Peragallo Urrutia","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gtc.2023.05.009_bib96","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/MIB.0000000000000134","article-title":"The impact of hormonal contraception on disease-related cyclical symptoms in women with inflammatory bowel diseases","volume":"20","author":"Gawron","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib97","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MIB.0000000000000642","article-title":"Current Transition Practices in Pediatric IBD: Findings from a National Survey of Pediatric Providers","volume":"22","author":"Gray","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2023.05.009_bib98","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/cch.12213","article-title":"Transition experience of young adults with inflammatory bowel diseases (IBD): a mixed methods study","volume":"41","author":"Plevinsky","year":"2015","journal-title":"Child Care Health Dev"},{"key":"10.1016\/j.gtc.2023.05.009_bib99","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11894-019-0739-9","article-title":"The Management Approach to the Adolescent IBD Patient: Health Maintenance and Medication Considerations","volume":"22","author":"Steinberg","year":"2020","journal-title":"Curr Gastroenterol Rep"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855323000602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855323000602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:41:49Z","timestamp":1760179309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855323000602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0889855323000602"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2023.05.009","relation":{},"ISSN":["0889-8553"],"issn-type":[{"type":"print","value":"0889-8553"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health Care Maintenance in Pediatric Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2023.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}